AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Dibaglim M 2mg/500mg Tablet SR

Metformin/glimepiride extended-release tablets (2mg/500mg) are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before use. Pregnant or lactating women require medical consultation prior to commencing treatment. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your doctor.

Uses of Dibaglim M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Dibaglim M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. It is recommended to take Dibaglim M 2mg/500mg Sustained-Release tablets with food.

Common Side effects of Dibaglim M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without crushing, chewing, or breaking it. Consume Dibaglim M 2mg/500mg Extended-Release tablets with food.

How Dibaglim M 2mg/500mg Tablet SR works:

Dibaglim M 2mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Dibaglim M 2mg/500mg SR tablets is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dibaglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Extended-release Dibaglim M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dibaglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. The medication is contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dibaglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Dibaglim M 2mg/500mg Tablet SR :

Should you forget a dose of Dibaglim M 2mg/500mg SR tablets, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 2mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes medication

FAQs on Dibaglim M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Dibaglim M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Dibaglim M 2mg/500mg Tablet SR and seek immediate medical attention.
Dibaglim M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 DM.
Dibaglim M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 2mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental Vitamin B12 is recommended at least annually, according to some researchers.
Dibaglim M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dibaglim M 2mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Dibaglim M 2mg/500mg Tabl...
108
MRP 132
18% off